Clinical Trials Logo

Moderate to Severe Alzheimer clinical trials

View clinical trials related to Moderate to Severe Alzheimer.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT00954590 Terminated - Clinical trials for Moderate to Severe Alzheimer

A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease

CONTACT
Start date: October 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if Dimebon is safe and effective in patients with moderate to severe Alzheimer's disease.